Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics

Journal of Pharmaceutical Sciences

Volumn 98, Issue 11, 2009, Pages 4191-4204

  Rizwan, S B ^a   Hanley, T ^b   Boyd, B J ^c   Rades, T ^a   Hook, S ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Controlled release; Diffusion; Kinetics; Lipids; Protein delivery

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; GLYCEROL OLEATE; LIPID; PHYTANTRIOL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; LIQUID CRYSTAL; SCANNING ELECTRON MICROSCOPY; SWELLING; WATER CONTENT; WATER LOADING; X RAY CRYSTALLOGRAPHY;

EID: 70349807814     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21724     Document Type: Article

References (45)

1. Collings PJ. 2002. Liquid crystals nature's delicate phase of matter. 2nd edition. New Jersey: Princeton University Press, Princeton.
2. Drummond CK, Fong C. 2000. Surfactant self-assembly objects as novel drug delivery vehicles. Curr Opin Colloid Interface Sci 4:449-456. (Pubitemid 30449773)
3. Clogston J, Craciun G, Hart DJ, Caffrey M. 2005. Controlling release from the lipidic cubic phase by selective alkylation. J Control Release 102:441-461. (Pubitemid 40093765)
4. Shah J, Sadhale Y, Chilukuri D. 2001. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev 47:229-250. (Pubitemid 32324116)
5. Clogston J, Caffrey M. 2005. Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids. J Control Release 107:97-111. (Pubitemid 41253706)
6. Lara MG, Bentley MV, Collet JH. 2005. In vitro drug release mechanism and drug loading studies of cubic phase gels. Int J Pharm 293:241-250.
7. Burrows R, Collett JH, Attwood D. 1994. The release of drugs from monoglyceride-water liquid crystalline phases. Int J Pharm 111:283-293. (Pubitemid 24292906)
8. Sadhale Y, Shah J. 1999. Stabilization of insulin against agitation-induced aggregation by the GMO cubic phase gel. Int J Pharm 191:51-64. (Pubitemid 29502177)
9. Sadhale Y, Shah J. 1999. Biological activity of insulin in GMO gels and the effect of agitation. Int J Pharm 191:65-74. (Pubitemid 29502178)
10. Shah MH, Paradkar A. 2005. Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme. Int J Pharm 294:161-171. (Pubitemid 40462332)
11. Boyd B, Whittaker D, Khoo S, Davey G. 2006. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm 309:216-226. (Pubitemid 43129485)
12. Fong C, Wells D, I K, Booth J, Hartley PJ. 2007. Synthesis and mesophases of glycerate surfactants. J Phys Chem B 111:1384-1392.
13. Hato M, Minamikawa H. 1996. The effects of oligo saccharide stereochemistry on the physical properties of aqueous synthetic lipids. Langmuir 12:1658-1665. (Pubitemid 126568154)
14. Chang C, Bodmeier R. 1997. Swelling of and drug release from monoglyceride-based drug delivery systems. J Pharm Sci 86:747-752. (Pubitemid 27248827)
15. Barauskas J, Landh T. 2003. Phase behaviour of the phytantriol/water system. Langmuir 19:9562-9565.
16. Ribier A, Biatry B. 1998. Cosmetic or dermatological composition in the form of an aqueous and stable dispersion of cubic gel particles based on phytanetriol and containing a surface-active agent which has a fatty chain, as dispersing and stabilizing agent. L'Oreal, Paris, United States.
17. Barauskas J, Johnsson M, Tiberg F. 2005. Self-assembled lipid superstructures: Beyond vesicles and liposomes. Nano Lett 5:1615-1619. (Pubitemid 41251697)
18. Dong Y, Larson I, Hanley T, Boyd BJ. 2006. Bulk and dispersed aqueous phase behavior of phytantriol: Effect of vitamin E acetate and F127 polymeron liquid crystal structure. Langmuir 22:9512-9518. (Pubitemid 44826357)
19. Dong Y, Dong A, Larson I, Rappolt M, Amenitsch H, Hanley T, Boyd BJ. 2008. Impurities in commercial phytantriol significantly alter its lyotropic liquid-crystalline phase behavior. Langmuir 24:6998-7003.
20. Caboi F, Amico GS, Pitzalis P, Monduzzi M, Nylander T, Larsson K. 2001. Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein/water system. I. Phase behavior. Chem Phys Lipids 109:47-62. (Pubitemid 32121742)
21. Helledi LS, Schubert L. 2001. Release kinetics of Acyclovir from a suspension of Acyclovir incorporated in a cubic phase delivery system. Drug Dev Indus Pharm 27:1073-1081. (Pubitemid 34053203)
22. Könnings S, Copland M, Davies N, Rades T. 2002. A method for the incorporation of ovalbumin into immune stimulating complexes prepared by the hydration method. Int J Pharm 241:385-389. (Pubitemid 34718040)
23. de Campo L, Yaghmur A, Sagalowicz L, Leser ME, Watzke H, Glatter O. 2004. Reversible phase transitions in emulsified nanostructured lipid systems. Langmuir 20:5254-5261.
24. Rosevear FB. 1954. The microscopy of the liquid crystalline neat and middle phases of soaps and synthetic detergents. J Am Oil Chem Soc 31:628-639.
25. Hyde S. 2001. Chapter 16 Identification of lyotropic liquid crystal mesophases. In: Holmberg K, editor. Handbook of applied surface and colloid chemistry. West Sussex, England: John Wiley & Sons Ltd. pp. 299-331.
26. Lee J, Choi SU, Yoon MK, Choi YW. 2003. Kinetic characterization of swelling of liquid crystalline phases of glyceryl monooleate. Arch Pharmacal Res 26:880-885. (Pubitemid 43073778)
27. Schott H. 1992. Kinetics of swelling of polymers and their gels. J Pharm Sci 81:467-470.
28. Rizwan SB, Dong Y, Boyd BJ, Rades T, Hook S. 2007. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Micron 38:478-485. (Pubitemid 46413070)
29. Higuchi WI. 1967. Diffusional models useful in biopharmaceutics. J Pharm Sci 56:315-324.
30. Lee KWY, Nguyen T, Hanley T, Boyd BJ. 2008. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drug. Int J Pharm 365:190-199.
31. Muller-Goymann C. 2004. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical application. Eur J Pharm Biopharm 58:343-356. (Pubitemid 39037240)
32. Boyd BJ, Rizwan SB, Dong Y, Hook S, Rades T. 2007. Self-assembled geometric liquid-crystalline nanoparticles imaged in three dimensions: Hexosomes are not necessarily flat hexagonal prisms. Langmuir 23:12461-12464. (Pubitemid 350275559)
33. Qui H, Caffery M. 2000. The phase diagram of the monoolein/water system: Metastability and equilibrium aspects. Biomaterials 21:223-234.
34. Engström S, Engström L. 1992. Phase behaviour of the lidocaine-monoolein-water system. Int J Pharm 79:113-122.
35. Lynch ML, Ofori-Boateng A, Hippe A, Kochvar K, Spicer P. 2003. Enhanced loading of water-soluble actives into bicontinuous cubic phase liquid crystals using cationic surfactants. J Colloid Interface Sci 260:404-413. (Pubitemid 36401600)
36. Wang Z, Zheng L, Inouue T. 2005. Effect of sucrose on the structure of a cubic phase formed from monoolein/water mixture. J Colloid Interface Sci 288:638-641. (Pubitemid 40779569)
37. Engström S, Lindhal L, Wallin R, Engblom J. 1992. A study of polar lipid drug carrier systems undergoing a thermosensitive lamellar-to-cubic phase transition. Int J Pharm 86:137-145.
38. Nylander T, Mattisson C, Razumas V, Meizis Y, Hakansson B. 1996. A study of entrapped enzyme stability and substrate diffusion in a monoglyceride-based cubic liquid crystalline phase. Colloids Surf B 114:311-320.
39. Zheng L, Zhang J, Shui L, Chen F, Um J, Chung H. 2003. Component effects on the phase behavior of monoglyceride-water mixtures studied by FT-IR and X-ray diffraction. J Disp Sci Tech 24:773-778. (Pubitemid 38075119)
40. Murgia S, Caboi F, Monduzzi M. 2001. Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein/water system II-13C NMR relaxation study. Chem Phys Lipids 110:11-17. (Pubitemid 32197584)
41. Chang C, Bodmeier R. 1997. Effect of dissolution media and additives on the drug release from cubic phase delivery systems. J Control Release 46:215-222. (Pubitemid 27132845)
42. Lee J, Kellaway IW. 2000. In vitro peptide release from liquid crystalline buccal delivery systems. Int J Pharm 195:29-33.
43. Engström S. 1990. Cubic phases as drug delivery systems. Polymer Preprints 31:157-158.
44. Larsson K. 2000. Aqueous dispersions of cubic lipid-water phases. Curr Opin Colloid Interface Sci 5:64-69. (Pubitemid 30705741)
45. Shearman GC, Templer RH, Seddon JM. 2006. Inverse lyotropic phases of lipids and membrane curvature. J Phys: Condensed Matter 18:S1105-S1124.